Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-01-02 @ 11:25 PM
Study NCT ID:
NCT03014635
Status:
COMPLETED
Last Update Posted:
2022-07-21
First Post:
2016-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
Sponsor:
Revance Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-22
First Submit QC Date:
None
Study First Post Date:
2017-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-02-15
Results First Submit QC Date:
None
Results First Post Date:
2022-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-10-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-06-29
Last Update Post Date:
2022-07-21
Last Update Post Date Type:
ACTUAL